The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS ...

Researchers from Denmark have uncovered strong evidence that depression often appears years before Parkinson’s disease and Lewy body dementia. The team, led by first author Christopher Rohde, analyzed ...

What started out as a medication for diabetes and weight loss is offering something quite unexpected for many women. Experts ...

Patients wey get movement disorders, including restless legs syndrome (RLS), dey tok say doctors no warn dem about serious ...

NRG Therapeutics has dosed the first participants in its Phase I clinical trial of NRG5051, being developed as a ...

The President of IMANI Africa, Franklin Cudjoe, has publicly disclosed that he has been living with Parkinson’s disease for ...

Explore off times in advanced Parkinson's disease, understand symptoms, communicate with your doctor, and consider treatment strategies and lifestyle adjustments.

Franklin Cudjoe, founder and CEO of the think tank IMANI Africa, has disclosed that he has been living with Parkinson’s ...

Patient-centric trial aiming to evaluate whether bezisterim can help delay disease progression reaches enrollment milestone - ...

It sounds like Lilly did just that. The U.S. pharma announced Wednesday that it was paying $14 per share of Ventyx—more than ...

The Founding President and Chief Executive Officer of the IMANI Centre for Policy and Education, Mr Franklin Cudjoe, has ...

Indian American physician to help accelerate commercial readiness for biotechnology firm’s cell therapy for Parkinson’s ...